LSB
LakeShore Biopharma
12 hedge funds and large institutions have $8.93M invested in LakeShore Biopharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.19%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
1
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$3.63M |
| 2 |
CAC
2
Cowen and Company
New York
|
$9.89K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$177 |
